The University of Chicago Header Logo

Kathleen Mullane

Concepts (346)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-Bacterial Agents
14
2019
885
2.440
Why?
Vancomycin
10
2016
79
2.110
Why?
Clostridium Infections
10
2022
132
2.110
Why?
Hematopoietic Stem Cell Transplantation
16
2023
979
1.770
Why?
Antifungal Agents
13
2020
127
1.730
Why?
Enterocolitis, Pseudomembranous
8
2019
52
1.710
Why?
Herpes Zoster
5
2019
26
1.690
Why?
Triazoles
10
2018
118
1.470
Why?
Aminoglycosides
7
2013
31
1.440
Why?
Antiviral Agents
10
2021
369
1.150
Why?
Herpes Zoster Vaccine
3
2019
6
1.130
Why?
Invasive Fungal Infections
5
2020
10
1.120
Why?
Nitriles
5
2018
172
0.930
Why?
Immunocompromised Host
12
2021
139
0.930
Why?
Pyridines
6
2018
317
0.910
Why?
Organophosphonates
3
2018
46
0.720
Why?
Cytosine
3
2018
124
0.680
Why?
Peptides, Cyclic
4
2016
43
0.660
Why?
Organ Transplantation
3
2019
307
0.630
Why?
Double-Blind Method
15
2023
1793
0.620
Why?
Cytomegalovirus Infections
5
2019
116
0.570
Why?
Mycoses
3
2020
46
0.540
Why?
Thiazoles
2
2014
127
0.510
Why?
Adenosine Monophosphate
3
2021
31
0.490
Why?
Lipopeptides
2
2016
20
0.490
Why?
Valine
1
2016
48
0.480
Why?
Alanine
3
2021
82
0.480
Why?
Herpesvirus 3, Human
1
2016
24
0.480
Why?
Acyclovir
1
2016
35
0.480
Why?
Drugs, Investigational
1
2016
36
0.480
Why?
Adult
43
2022
29698
0.450
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2016
177
0.440
Why?
Middle Aged
39
2020
29642
0.420
Why?
Aged
29
2020
21986
0.420
Why?
Transplant Recipients
6
2023
182
0.410
Why?
Invasive Pulmonary Aspergillosis
3
2018
8
0.390
Why?
Daptomycin
1
2013
3
0.380
Why?
Male
50
2020
47475
0.380
Why?
Humans
68
2024
98799
0.380
Why?
Minocycline
1
2013
14
0.380
Why?
Edetic Acid
1
2013
40
0.380
Why?
Biofilms
1
2013
54
0.370
Why?
Treatment Outcome
21
2020
9806
0.360
Why?
Practice Guidelines as Topic
1
2019
1116
0.350
Why?
Methicillin-Resistant Staphylococcus aureus
1
2013
85
0.350
Why?
Female
42
2020
51997
0.350
Why?
Actinomycetales
1
2011
5
0.340
Why?
Nucleic Acid Synthesis Inhibitors
1
2011
16
0.340
Why?
Respiratory Syncytial Virus Infections
2
2020
26
0.320
Why?
Administration, Oral
6
2018
677
0.320
Why?
Neoplasms
2
2019
3382
0.320
Why?
Ethanol
1
2013
287
0.310
Why?
HIV Infections
4
2013
1024
0.310
Why?
Aged, 80 and over
10
2018
7461
0.300
Why?
Renal Insufficiency, Chronic
1
2013
271
0.300
Why?
Gastrointestinal Tract
1
2011
198
0.290
Why?
Respiratory Tract Infections
2
2020
112
0.280
Why?
Hematologic Neoplasms
3
2020
384
0.280
Why?
Administration, Intravenous
5
2020
64
0.270
Why?
Mucormycosis
4
2018
15
0.260
Why?
Acetates
2
2017
63
0.230
Why?
Young Adult
9
2018
7598
0.230
Why?
Randomized Controlled Trials as Topic
3
2018
995
0.230
Why?
Diarrhea
4
2015
180
0.230
Why?
Pneumonia, Viral
2
2020
343
0.220
Why?
Coronavirus Infections
2
2020
339
0.220
Why?
Legionellosis
1
2024
6
0.210
Why?
Quinazolines
2
2017
222
0.210
Why?
Legionella
1
2024
16
0.210
Why?
Adolescent
13
2018
10168
0.210
Why?
Endocarditis, Bacterial
1
2024
38
0.210
Why?
Vaccination
2
2019
328
0.210
Why?
Transplantation, Homologous
4
2016
1029
0.200
Why?
Severe Acute Respiratory Syndrome
1
2003
9
0.200
Why?
Pneumococcal Infections
1
2023
44
0.190
Why?
Cytomegalovirus
3
2018
74
0.190
Why?
Vaccines, Inactivated
2
2019
32
0.180
Why?
Clinical Trials, Phase III as Topic
2
2013
172
0.170
Why?
Drug-Related Side Effects and Adverse Reactions
3
2018
220
0.170
Why?
Mycobacterium chelonae
1
2021
4
0.170
Why?
Reaction Time
2
1999
323
0.170
Why?
DNA, Viral
3
2017
238
0.170
Why?
Mycobacterium Infections, Nontuberculous
1
2021
25
0.170
Why?
Coronary Disease
2
1995
227
0.160
Why?
Agammaglobulinemia
1
2020
21
0.160
Why?
Betacoronavirus
2
2020
288
0.160
Why?
Drug Resistance, Viral
2
2019
37
0.160
Why?
Kaplan-Meier Estimate
4
2017
909
0.150
Why?
Injection Site Reaction
1
2019
2
0.150
Why?
Cardiomyopathies
2
2017
316
0.150
Why?
Fecal Microbiota Transplantation
2
2022
89
0.150
Why?
Anti-HIV Agents
2
1999
215
0.150
Why?
Severity of Illness Index
3
2017
2025
0.150
Why?
Bordetella Infections
1
2018
5
0.140
Why?
Aminoimidazole Carboxamide
2
1995
8
0.140
Why?
Bacterial Infections
1
2020
184
0.140
Why?
Drug Therapy, Combination
5
2011
766
0.140
Why?
Recurrence
3
2017
1274
0.140
Why?
Ribonucleosides
2
1995
22
0.140
Why?
Mycobacterium tuberculosis
1
2021
214
0.140
Why?
Neutrophils
4
1999
346
0.130
Why?
Psychomotor Performance
3
2000
511
0.130
Why?
Coinfection
1
2018
72
0.130
Why?
Diagnostic Errors
1
2018
161
0.130
Why?
Survival Analysis
2
2018
1530
0.130
Why?
Chemoprevention
1
2017
93
0.130
Why?
Renal Insufficiency
1
2018
101
0.130
Why?
Neutropenia
1
2018
211
0.130
Why?
Herpesvirus 6, Human
1
2017
15
0.130
Why?
Microbial Sensitivity Tests
3
2012
151
0.120
Why?
Investigational New Drug Application
1
2016
2
0.120
Why?
Antineoplastic Agents
2
2019
2386
0.120
Why?
Foscarnet
1
2016
9
0.120
Why?
Zygomycosis
2
2007
3
0.120
Why?
Disease Management
1
2019
378
0.120
Why?
Myocarditis
1
2017
61
0.120
Why?
Infectious Disease Transmission, Vertical
1
2016
36
0.120
Why?
Hepatitis B virus
1
2016
49
0.120
Why?
Health Behavior
1
2017
203
0.120
Why?
Hepatitis B
1
2016
78
0.110
Why?
Antibiotic Prophylaxis
1
2016
87
0.110
Why?
Mannans
1
2015
6
0.110
Why?
beta-Glucans
1
2015
7
0.110
Why?
Pregnancy Complications, Infectious
1
2016
100
0.110
Why?
Societies, Medical
1
2019
687
0.110
Why?
Candida
2
2012
20
0.110
Why?
Cognition
1
1999
672
0.100
Why?
Graft vs Host Disease
1
2016
382
0.100
Why?
Tissue Plasminogen Activator
1
1995
180
0.100
Why?
Opportunistic Infections
1
2014
57
0.100
Why?
Multivariate Analysis
2
2013
1007
0.100
Why?
Vaccines, Attenuated
1
2013
53
0.100
Why?
Fibrinolytic Agents
1
1995
244
0.100
Why?
Aspergillus
3
2018
9
0.100
Why?
Histoplasmosis
1
2013
29
0.100
Why?
Clinical Medicine
1
2013
27
0.100
Why?
Clinical Laboratory Techniques
1
2013
79
0.090
Why?
Drug Combinations
1
2013
202
0.090
Why?
Amphotericin B
2
2009
33
0.090
Why?
Enterococcus
1
2012
34
0.090
Why?
HIV-1
3
1998
179
0.090
Why?
Prospective Studies
6
2015
4837
0.090
Why?
Drug Administration Schedule
3
2020
837
0.090
Why?
DNA-Directed RNA Polymerases
1
2011
99
0.080
Why?
Cross Infection
1
2011
155
0.080
Why?
Mucor
1
2009
3
0.080
Why?
Microbiota
1
2015
473
0.070
Why?
Fungi
3
2018
70
0.070
Why?
Thromboxane-A Synthase
1
1989
4
0.070
Why?
Glycosides
1
2008
12
0.070
Why?
Multiple Myeloma
2
2018
372
0.070
Why?
Retrospective Studies
2
2021
11104
0.070
Why?
Angiotensin-Converting Enzyme Inhibitors
1
1989
99
0.070
Why?
Myocardial Reperfusion Injury
1
1989
57
0.070
Why?
Gastrointestinal Diseases
1
2009
156
0.070
Why?
Arachidonic Acids
1
1988
37
0.070
Why?
Acquired Immunodeficiency Syndrome
2
1999
68
0.060
Why?
AIDS Dementia Complex
2
1998
7
0.060
Why?
Substance-Related Disorders
2
2003
470
0.060
Why?
Aspergillosis
2
2018
39
0.060
Why?
Leukemia, Myeloid, Acute
2
2017
850
0.060
Why?
Feces
3
2014
392
0.060
Why?
Treatment Failure
2
2019
300
0.060
Why?
Salvage Therapy
1
2007
241
0.060
Why?
Fungemia
1
2005
15
0.060
Why?
Candidiasis
1
2005
40
0.060
Why?
Child
6
2022
7771
0.060
Why?
Bacterial Proteins
1
2011
901
0.050
Why?
Lipoproteins
1
2005
136
0.050
Why?
CD4 Lymphocyte Count
3
1999
75
0.050
Why?
Urokinase-Type Plasminogen Activator
1
2004
49
0.050
Why?
Incidence
3
2014
1798
0.050
Why?
United States
4
2022
8387
0.050
Why?
Pyrimidines
1
2007
416
0.050
Why?
Hospitalization
2
2020
993
0.050
Why?
Pandemics
2
2020
923
0.050
Why?
Dose-Response Relationship, Drug
3
2014
1949
0.050
Why?
Graft Occlusion, Vascular
1
2004
92
0.050
Why?
Fatal Outcome
1
2024
295
0.050
Why?
Catheters, Indwelling
1
2004
102
0.050
Why?
Vaccines, Conjugate
1
2023
9
0.050
Why?
Voriconazole
2
2018
19
0.050
Why?
Pneumococcal Vaccines
1
2023
32
0.050
Why?
Immunogenicity, Vaccine
1
2023
22
0.050
Why?
Patient Isolation
1
2003
14
0.050
Why?
Catheterization, Central Venous
1
2004
115
0.050
Why?
Disaster Planning
1
2003
26
0.050
Why?
Antibodies, Bacterial
1
2023
106
0.050
Why?
Zidovudine
2
1999
12
0.050
Why?
HIV Seropositivity
2
2000
49
0.050
Why?
Recombinant Proteins
3
2004
994
0.040
Why?
Platelet Aggregation
2
1994
40
0.040
Why?
Cell- and Tissue-Based Therapy
1
2022
65
0.040
Why?
Leukoencephalopathy, Progressive Multifocal
1
2001
8
0.040
Why?
AIDS-Related Opportunistic Infections
1
2001
24
0.040
Why?
Immunoglobulin G
1
2023
481
0.040
Why?
Granulocyte Colony-Stimulating Factor
2
1999
158
0.040
Why?
Secondary Prevention
2
2013
194
0.040
Why?
Antiretroviral Therapy, Highly Active
1
2001
73
0.040
Why?
Patient Acuity
1
2020
38
0.040
Why?
Verbal Learning
1
2000
31
0.040
Why?
Child, Preschool
4
2013
4053
0.040
Why?
Immunoglobulins, Intravenous
1
2020
67
0.040
Why?
Respiratory System
1
2020
120
0.040
Why?
Zalcitabine
1
1999
1
0.040
Why?
Didanosine
1
1999
1
0.040
Why?
CD4-CD8 Ratio
1
1999
18
0.040
Why?
Oxygen Inhalation Therapy
1
2020
71
0.040
Why?
Lung Transplantation
1
2024
390
0.040
Why?
Diagnosis, Differential
1
2003
1571
0.040
Why?
Bordetella bronchiseptica
1
2018
6
0.040
Why?
Statistics, Nonparametric
1
1999
304
0.040
Why?
Bordetella pertussis
1
2018
17
0.040
Why?
Biomarkers
2
2016
2026
0.040
Why?
Multiplex Polymerase Chain Reaction
1
2018
38
0.040
Why?
Phagocytes
1
1998
16
0.040
Why?
Cross Reactions
1
2018
116
0.030
Why?
Infant
3
2016
3368
0.030
Why?
Odds Ratio
1
2020
728
0.030
Why?
False Positive Reactions
1
2018
214
0.030
Why?
Mucorales
1
2018
2
0.030
Why?
Reactive Oxygen Species
2
1998
526
0.030
Why?
Choice Behavior
1
1999
165
0.030
Why?
DNA, Bacterial
1
2018
236
0.030
Why?
Rare Diseases
1
2018
75
0.030
Why?
Blood Platelets
2
1989
153
0.030
Why?
Psychiatric Status Rating Scales
1
1999
508
0.030
Why?
Dogs
2
1995
642
0.030
Why?
Allografts
1
2018
221
0.030
Why?
Terminology as Topic
1
2019
226
0.030
Why?
Biopsy
1
2021
1226
0.030
Why?
Memory Disorders
1
1997
76
0.030
Why?
Social Isolation
1
2017
73
0.030
Why?
Transplantation, Autologous
1
2018
398
0.030
Why?
Hepatitis B e Antigens
1
2016
9
0.030
Why?
Hepatitis B Surface Antigens
1
2016
26
0.030
Why?
Hepatitis B Antibodies
1
2016
16
0.030
Why?
Parturition
1
2016
21
0.030
Why?
Pilot Projects
1
1999
978
0.030
Why?
Memory, Short-Term
1
2000
260
0.030
Why?
Lymphoma
1
2018
255
0.030
Why?
Femoral Vein
1
2016
43
0.030
Why?
Immunization
1
2016
154
0.030
Why?
Fetal Blood
1
2016
95
0.030
Why?
Disease-Free Survival
1
2018
1196
0.030
Why?
Leukemia
1
2018
310
0.030
Why?
Prognosis
2
2015
4139
0.030
Why?
Enema
1
2015
37
0.030
Why?
Infant, Newborn
2
2016
2556
0.030
Why?
Viral Load
1
2016
162
0.030
Why?
Galactose
1
2015
29
0.030
Why?
Risk Factors
2
2019
6295
0.030
Why?
Health Status
1
2017
388
0.030
Why?
Mothers
1
2016
150
0.030
Why?
5,8,11,14-Eicosatetraynoic Acid
1
1994
2
0.030
Why?
Case-Control Studies
1
1999
2017
0.030
Why?
Catalase
1
1994
46
0.030
Why?
Peroxidase
1
1994
54
0.030
Why?
Placenta
1
2016
202
0.030
Why?
Registries
1
2020
1133
0.030
Why?
Myelodysplastic Syndromes
1
2017
386
0.030
Why?
Apoptosis
2
1999
1754
0.030
Why?
Survival Rate
1
2018
2057
0.030
Why?
Mental Recall
1
1995
172
0.030
Why?
Perfusion
1
1995
272
0.030
Why?
Animals
5
2016
29045
0.020
Why?
Attention
1
1998
435
0.020
Why?
Luminescent Measurements
3
1999
64
0.020
Why?
Cross-Sectional Studies
1
1999
2077
0.020
Why?
Arachidonic Acid
2
1994
63
0.020
Why?
Free Radicals
2
1994
72
0.020
Why?
Limit of Detection
1
2012
22
0.020
Why?
Canada
1
2012
210
0.020
Why?
Drug Resistance, Bacterial
1
2012
89
0.020
Why?
Polymerase Chain Reaction
1
2013
895
0.020
Why?
Adenosine
1
1994
291
0.020
Why?
Intention to Treat Analysis
1
2011
82
0.020
Why?
Neuropsychological Tests
3
1998
571
0.020
Why?
Logistic Models
1
2013
1276
0.020
Why?
Magnetic Resonance Imaging
1
2001
3622
0.020
Why?
Phenylacetates
1
1989
3
0.020
Why?
Rats, Inbred SHR
1
1989
33
0.020
Why?
Hydralazine
1
1989
22
0.020
Why?
Respiratory Burst
2
1999
19
0.020
Why?
Indomethacin
1
1989
58
0.020
Why?
Surveys and Questionnaires
1
2017
3058
0.020
Why?
Fatty Acids, Unsaturated
1
1989
29
0.020
Why?
Pregnancy
1
2016
3286
0.020
Why?
Benzazepines
1
1989
64
0.020
Why?
Drug Synergism
1
1989
317
0.020
Why?
Eicosanoic Acids
1
1988
2
0.020
Why?
Lipoxygenase
1
1988
9
0.020
Why?
SRS-A
1
1988
27
0.020
Why?
Platelet Activating Factor
1
1988
53
0.020
Why?
Cell Communication
1
1989
223
0.020
Why?
Superoxides
1
1988
76
0.020
Why?
Serotonin
1
1988
211
0.020
Why?
Sulfonamides
1
1989
352
0.010
Why?
Echinocandins
1
2005
5
0.010
Why?
Internationality
1
2005
80
0.010
Why?
Blood Pressure
1
1989
923
0.010
Why?
Placebos
1
2004
210
0.010
Why?
Age Distribution
1
2004
211
0.010
Why?
Kidney
1
1989
1126
0.010
Why?
Oxygen
1
1988
777
0.010
Why?
Rats
1
1989
4079
0.010
Why?
Hemorrhage
1
2004
297
0.010
Why?
Kinetics
1
2004
1478
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2000
374
0.010
Why?
Filgrastim
1
1999
56
0.010
Why?
Problem Solving
1
1998
59
0.010
Why?
Receptors, Immunologic
1
1998
143
0.010
Why?
Acridine Orange
1
1996
2
0.010
Why?
Ethidium
1
1996
13
0.010
Why?
Electrophoresis, Agar Gel
1
1996
42
0.010
Why?
Histocytochemistry
1
1996
122
0.010
Why?
Cell Size
1
1996
72
0.010
Why?
Microscopy, Electron
1
1996
435
0.010
Why?
HIV Seronegativity
1
1995
12
0.010
Why?
Microscopy, Fluorescence
1
1996
435
0.010
Why?
Flow Cytometry
1
1996
722
0.010
Why?
Adenosine Kinase
1
1994
1
0.010
Why?
Tubercidin
1
1994
1
0.010
Why?
Blood Physiological Phenomena
1
1994
9
0.010
Why?
Purinergic P1 Receptor Antagonists
1
1994
6
0.010
Why?
Scintillation Counting
1
1994
5
0.010
Why?
Dipyridamole
1
1994
12
0.010
Why?
Substance Abuse, Intravenous
1
1995
76
0.010
Why?
Coronary Thrombosis
1
1994
15
0.010
Why?
Theophylline
1
1994
34
0.010
Why?
Plasma
1
1994
49
0.010
Why?
Cell Survival
1
1996
1018
0.010
Why?
Adenosine Deaminase
1
1994
31
0.010
Why?
Regional Blood Flow
1
1994
194
0.010
Why?
Psychometrics
1
1995
359
0.010
Why?
Erythrocytes
1
1994
242
0.010
Why?
Aspirin
1
1994
168
0.010
Why?
Tumor Cells, Cultured
1
1994
1029
0.010
Why?
Coronary Vessels
1
1994
182
0.010
Why?
Glioblastoma
1
1994
301
0.010
Why?
Cohort Studies
1
1998
3242
0.010
Why?
Oxidative Stress
1
1994
490
0.010
Why?
DNA
1
1996
1274
0.010
Why?
Reproducibility of Results
1
1995
2799
0.000
Why?
Disease Models, Animal
1
1994
2581
0.000
Why?
Prostatic Neoplasms
1
1994
1846
0.000
Why?
Mullane's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (346)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_